Conjugated proteins with prolonged in vivo efficacy

Details for Australian Patent Application No. 2009279090 (hide)

Owner Novo Nordisk Health Care AG

Inventors Behrens, Carsten; Garibay, Patrick William; Ostergaard, Soren; Andersen, Henrik Sune; Johansen, Nils Langeland; Peschke, Bernd; Bak, Sonja

Agent Shelston IP

Pub. Number AU-A-2009279090

PCT Pub. Number WO2010/015668

Priority 08161905.8 06.08.08 EP

Filing date 6 August 2009

Wipo publication date 11 February 2010

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/015668 Priority application(s): WO2010/015668

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009279093-Method and device for assisting the driver of a vehicle, especially an industrial or commercial vehicle, in identifying obstacles nearby with ultrasound sensors

2009279089-Cyclohexyl amide derivatives and their use as CRF-1 receptor antagonists